Related Experiment Videos
Changes in venous capacitance during prostaglandin E1-induced hypotension; comparisons with trinitroglycerin
1Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Journal of Anesthesia
|July 1, 1993
Summary
Prostaglandin E1 (PGE1) affects venous capacitance during controlled hypotension. While similar to Trinitroglycerin (TNG) in moderate hypotension, PGE1 shows less impact in deeper hypotension.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Venous capacitance is crucial for maintaining blood pressure during hypotension.
- Prostaglandin E1 (PGE1) is a vasodilator with potential effects on venous tone.
- Trinitroglycerin (TNG) is a standard agent for inducing controlled hypotension.
Purpose of the Study:
- To investigate the impact of Prostaglandin E1 (PGE1) on venous capacitance.
- To compare the effects of PGE1 with Trinitroglycerin (TNG) during controlled hypotension.
Main Methods:
- Rats were anesthetized and subjected to controlled hypotension using intravenous infusions of PGE1 or TNG.
- Mean arterial pressure was reduced to 70 mmHg and 50 mmHg.
- Venous capacitance was assessed by measuring mean circulatory filling pressure (MCFP) before and during hypotension.
Main Results:
- PGE1 significantly decreased MCFP at both 70 mmHg and 50 mmHg mean arterial pressure.
- The reduction in MCFP by PGE1 was comparable to TNG at 70 mmHg.
- At 50 mmHg, PGE1 caused a significantly smaller decrease in MCFP compared to TNG.
Conclusions:
- PGE1 increases venous capacitance during controlled hypotension.
- PGE1's effect on venous capacitance is similar to TNG in moderate hypotension but less pronounced in deep hypotension.
- PGE1 may be a useful alternative to TNG for controlled hypotension, with potentially different effects at deeper levels.